319
Views
8
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Effects of a cream containing 5% hyaluronic acid mixed with a bacterial-wall-derived glycoprotein, glycyrretinic acid, piroctone olamine and climbazole on signs, symptoms and skin bacterial microbiota in subjects with seborrheic dermatitis of the face

, , , , , , , , , , , & show all
Pages 285-293 | Published online: 02 May 2019

References

  • Borda LJ, Wikramanayake TC. Seborrheic dermatitis and dandruff: a comprehensive review. J Clin Investig Dermatol. 2015;3(2):1–22.
  • Naldi L, Rebora A. Seborrheic dermatitis. N Engl J Med. 2009;360(4):387–396. doi:10.1056/NEJMcp080646419164189
  • Faergemann J, Jones TC, Hettler O, Loria Y. Pityrosporum ovale (Malassezia furfur) as the causative agent of seborrhoeic dermatitis: new treatment options. Br J Dermatol. 1996;134:12–15.8763461
  • Kim GK. Seborrheic dermatitis and Malassezia species: how are they related? J Clin Aesthet Dermatol. 2009;2(11):14.20725575
  • Tanaka A, Cho O, Saito M, Tsuboi R, Kurakado S, Sugita T. Molecular characterization of the skin fungal microbiota in patients with seborrheic dermatitis. J Clin Exp Dermatol Res. 2014;5:239.
  • Clavaud C, Jourdain R, Bar-Hen A, et al. Dandruff is associated with disequilibrium in the proportion of the major bacterial and fungal populations colonizing the scalp. PLoS One. 2013;8(3):e58203. doi:10.1371/journal.pone.005820323483996
  • Tanaka A, Cho O, Saito C, Saito M, Tsuboi R, Sugita T. Comprehensive pyrosequencing analysis of the bacterial microbiota of the skin of patients with seborrheic dermatitis. Microbiol Immunol. 2016;60(8):521–526. doi:10.1111/1348-0421.1239827301664
  • Milani M, Barcella A, Puviani M. Efficacy of a corticosteroid-free, 5% hyaluronic-based facial cream in the treatment of seborrheic dermatitis. A Proof-of-Concept Study. J Clin Exp Dermatol Res. 2017;8:6–10.
  • Puri KS, Suresh KR, Gogtay NJ, et al. Declaration of Helsinki, 2008: implications for stakeholders in research. J Postgrad Med. 2009;55:131. doi:10.4103/0022-3859.5284619550060
  • Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2004;18(1):13–26.14678527
  • Gupta AK, Madzia SE, Batra R. Etiology and management of seborrheic dermatitis. Dermatology. 2004;208(2):89–93. doi:10.1159/00007647815056994
  • Peter RU, Richarz‐Barthauer U. Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double‐blind, placebo‐controlled trial. Br J Dermatol. 1995;132(3):441–445.7718463
  • DeAngelis YM, Gemmer CM, Kaczvinsky JR, Kenneally DC, Schwartz JR, Dawson TL Jr. Three etiologic facets of dandruff and seborrheic dermatitis: malassezia fungi, sebaceous lipids, and individual sensitivity. J Investig Dermatol Symp Proc. 2005;10(3):295–297. doi:10.1111/j.1087-0024.2005.10119.x Elsevier.
  • Dessinioti C, Katsambas A. Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies. Clin Dermatol. 2013;31(4):343–351. doi:10.1016/j.clindermatol.2013.01.00123806151
  • Gupta AK, Nicol K, Batra R. Role of antifungal agents in the treatment of seborrheic dermatitis. Am J Clin Dermatol. 2004;5(6):417–422. doi:10.2165/00128071-200405060-0000615663338
  • Johnson BA, Nunley JR. Treatment of seborrheic dermatitis. Am Fam Physician. 2000;61(9):2703–2710.10821151
  • Park T, Kim HJ, Myeong NR, et al. Collapse of human scalpmicrobiome network in dandruff and seborrhoeicdermatitis. ExpDermatol. 2017;26(9):835–838. doi:10.1111/exd.13293
  • Stratigos JD, Antoniou CHR, Katsambas A, et al. Ketoconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis: a double-blind comparative study. J Am Acad Dermatol. 1988;19(5):850–853.2973476
  • Park HK, Ha MH, Park SG, Kim MN, Kim BJ, Kim W. Characterization of the fungal microbiota (mycobiome) in healthy and dandruff-afflicted human scalps. PLoS One. 2012;7(2):e32847. doi:10.1371/journal.pone.003284722393454
  • Xu Z, Wang Z, Yuan C, et al. Dandruff is associated with the conjoined interactions between host and microorganisms. Sci Rep. 2016;6:srep24877. doi:10.1038/srep24877
  • Shu M, Wang Y, Yu J, et al. Fermentation of Propionibacterium acnes, a commensal bacterium in the human skin microbiome, as skin probiotics against methicillin-resistant Staphylococcus aureus. PLoS One. 2013;8(2):e55380. doi:10.1371/journal.pone.005538023405142
  • Wang Y, Kuo S, Shu M, et al. Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris. Appl Microbiol Biotechnol. 2014;98(1):411–424. doi:10.1007/s00253-013-5394-824265031
  • Zeeuwen PL, Boekhorst J, van Den Bogaard EH, et al. Microbiome dynamics of human epidermis following skin barrier disruption. Genome Biol. 2012;13(11):R101. doi:10.1186/gb-2012-13-11-r10123153041
  • Schlesinger T, Powell CR. Efficacy and safety of a low-molecular weight hyaluronic Acid topical gel in the treatment of facial seborrheic dermatitis. J Clin Aesthet Dermatol. 2012;5(10):20.
  • Manuskiatti W, Maibach HI. Hyaluronic acid and skin: wound healing and aging. Int J Dermatol. 1996;35(8):539–544.8854147
  • SanMiguel A, Grice EA. Interactions between host factors and the skin microbiome. Cell Mol Life Sci. 2015;72(8):1499–1515. doi:10.1007/s00018-014-1812-z25548803
  • Neuman MG, Nanau RM, Oruña-Sanchez L, Coto G. Hyaluronic acid and wound healing. J Pharm Pharm Sci. 2015;18(1):53–60.25877441
  • Mast BA, Flood LC, Haynes JH, et al. Hyaluronic acid is a major component of the matrix of fetal rabbit skin and wounds: implications for healing by regeneration. Matrix. 1991;11(1):63–68.2027330
  • Mukherjee S, Mitra R, Maitra A, et al. Sebum and hydration levels in specific regions of human face significantly predict the nature and diversity of facial skin microbiome. Sci Rep. 2016;6:36062. doi:10.1038/srep3606227786295
  • Youn HJ, Kim SY, Park M, et al. Efficacy and safety of cream containing climbazole/piroctone olamine for facial seborrheic dermatitis: a single-center, open-label split-face clinical study. Ann Dermatol. 2016;28(6):733–739. doi:10.5021/ad.2016.28.6.73327904273
  • Hussain H, Green IR, Shamraiz U, et al. Therapeutic potential of glycyrrhetinic acids: a patent review (2010–2017). Expert Opin Ther Pat. 2018;28(5):383–398. doi:10.1080/13543776.2018.145582829558289
  • Teelucksingh S, Mackie ADR, Burt D, Edwards CRW, Mclntyre MA, Brett L. Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. Lancet. 1990;335(8697):1060–1063. doi:10.1016/0140-6736(90)92633-S1970371
  • Turlier V, Viode C, Durbise E, et al. Clinical and biochemical assessment of maintenance treatment in chronic recurrent seborrheic dermatitis: randomized controlled study. Dermatol Ther (Heidelb). 2014;4(1):43–59. doi:10.1007/s13555-014-0047-024643869
  • Hanisch FG, Schwientek T, Von Bergwelt‐Baildon MS, Schultze JL, Finn O. O‐Linked glycans control glycoprotein processing by antigen‐presenting cells: a biochemical approach to the molecular aspects of MUC1 processing by dendritic cells. Eur J Immunol. 2003;33(12):3242–3254. doi:10.1002/eji.20032418914635032